Masayuki Murota

发表

Discovery of 4-[4-({(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undec-9-yl}methyl)phenoxy]benzoic acid hydrochloride: a highly potent orally available CCR5 selective antagonist.

H. Mitsuya, K. Maeda, H. Nakai, 2011, Bioorganic & medicinal chemistry.

Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines.

S. Kusuda, K. Hirai, M. Toda, 2003, Bioorganic & medicinal chemistry.

Structure and synthesis of arnottin I : a 6H-benzo[d]naphtho[1,2-b]pyran-6-one derivative from a plant source

T. Ishikawa, T. Harayama, Masayuki Murota, 1993 .

Further optimization of sulfonamide analogs as EP1 receptor antagonists: synthesis and evaluation of bioisosteres for the carboxylic acid group.

M. Toda, T. Matsui, S. Ohuchida, 2006, Bioorganic & medicinal chemistry.

Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Identification of 2-azabicyclo[4.1.0]heptan-3-imines.

S. Kusuda, K. Hirai, M. Toda, 2003, Bioorganic & medicinal chemistry.

Design and synthesis of inhibitors of inducible nitric oxide synthase. Discovery of a new chemical lead with potential for oral bioavailability.

S. Kusuda, K. Hirai, M. Toda, 2003, European journal of medicinal chemistry.

Structure and Synthesis of Arnottin I: A 6H‐Benzo(d)naphtho(1,2‐b) pyran‐6‐one Derivative from a Plant Source.

T. Ishikawa, T. Harayama, Masayuki Murota, 2010 .

Arnottin II, a unique spiro compound composed of a 3, 4-dehydro-1-tetralone and a phthalide skeleton: Is it biosynthetically related to a benzo[c]phenanthridine alkaloid ?

T. Ishikawa, Toshiko Watanabe, T. Harayama, 1995 .

Discovery of heteroaryl sulfonamides as new EP1 receptor selective antagonists.

M. Toda, T. Matsui, Shingo Yamamoto, 2006, Bioorganic & medicinal chemistry.